This content is from: Premium
A New Biotech Fund for Suvretta
Averill will be completely separate from Suvretta’s existing funds but share the firm’s infrastructure.
Suvretta Capital Management is raising money for a new fund that will launch on April 1.The fund, called Averill, will be completely separate from Suvretta’s existing funds but will use the firm’s infrastructure, according to a Suvretta investor.Averill will be a long-short fund specializing in biotech stocks and led by
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.